Anticancer strategies by upregulating p53 through inhibition of its ubiquitination by MDM2
The potentiation of p53 activity through inhibition of its negative regulator MDM2 is an
attractive strategy for anticancer therapy. Much progress has been made in the last decade …
attractive strategy for anticancer therapy. Much progress has been made in the last decade …
[HTML][HTML] Apoptosis-inducing activity of synthetic hydrocarbon-stapled peptides in H358 cancer cells expressing KRASG12C
C Li, N Zhao, L An, Z Dai, X Chen, F Yang… - … Pharmaceutica Sinica B, 2021 - Elsevier
Lung cancers are the leading cause of cancer deaths worldwide and pose a grave threat to
human life and health. Non-small cell lung cancer (NSCLC) is the most frequent malignancy …
human life and health. Non-small cell lung cancer (NSCLC) is the most frequent malignancy …